TrialIndian heart journal
Comparison of the efficacy, safety, and tolerability of the FDC of telmisartan + bisoprolol with telmisartan + metoprolol succinate ER combination therapy for stage 1 and stage 2 hypertension: A double-blind, multicentric, phase-III clinical study.
Gurpreet S Wander et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
pooled itcites it